Search Results
Results found for "Tectonic Therapeutic"
- Ep 70 with Dr. Stephen Ferguson
Brian Collier in the Department of Pharmacology and Therapeutics at McGill University (1994).
- Distinct sub-cellular signal propagation as a component of functional selectivity
of Canada (2014), the Julie Axelrod award from the American Society of Pharmacology and Exerimental Therapeutics
- Ep 69 with Dr. Stephen Ferguson
Brian Collier in the Department of Pharmacology and Therapeutics at McGill University (1994).
- Ep 53 with Dr. Timo De Groof
nanobodies as research tools, to investigate different GPCR conformations, while also focusing on their therapeutic
- GPCR Retreat 2023 - Part I
protein-coupled receptors (GPCRs) regulate motivated behavior and how these receptors can be targeted for therapeutic distinct signaling pathways with their physiological effects and may serve as the basis for more selective therapeutics
- University Pricing | Dr. GPCR Ecosystem
Courses On-demand GPCR courses created by leading experts, covering everything from basics to advanced therapeutics exclusive access to premium positions. 200+ Expert Talks Expert presentations across discovery and therapeutics
- Ep 146 with Dr Michael Feigin
Michael Feigin is an Associate Professor in the Department of Pharmacology and Therapeutics, and Director of Graduate Studies of Experimental Therapeutics at Roswell Park Comprehensive Cancer Center in Buffalo disrupting histone processing on rapidly proliferating cells, such as cancer cells, and suggested a therapeutic
- Ep 113 with Dr. Prasenjit Saha
receptors would be a significant breakthrough in cardiovascular biology as they could be targeted for therapeutic
- Ep 153 with Dr Jacek Mokrosiński
Yamina will schedule a future talk with Jacek about GPCRs as therapeutic modalities. The discussion revealed their interest in GPCRs as therapeutic modalities and possible future collaborations
- U-Course-Lecturers Details | Dr. GPCR Ecosystem
students, and industry professionals eager to deepen their knowledge of GPCR signaling, pharmacology, and therapeutic Terry Kenakin Development of GPCR Ligands and Therapeutic Drugs Up March 20 – April 10 4 weeks x 1 hour
- Ep 36 with Dr. Michel Bouvier
of Canada (2014), the Julie Axelrod award from the American Society of Pharmacology and Exerimental Therapeutics
- Session II | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
understanding the molecular basis for human tumor development and how to use this knowledge to devise new therapeutics Van Meir has developed novel therapeutic approaches for cancer using oncolytic adenoviruses and anti-angiogenic
- Session VIII | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
GPCRs in the regulation of physiologic/pathologic function in the heart in an effort to uncover novel therapeutic
- Ep 149 with Dr Arthur Christopoulos
Award and the Goodman and Gilman Award from the American Society for Pharmacology and Experimental Therapeutics Institute, highlighting its translational approach to research and its capacity to translate research into therapeutic
- Ep 148 with Dr Arthur Christopoulos
Award and the Goodman and Gilman Award from the American Society for Pharmacology and Experimental Therapeutics Institute, highlighting its translational approach to research and its capacity to translate research into therapeutic
- Session I | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Departments of Psychiatry and Molecular Pharmacology and Therapeutics, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA; Division of Molecular Therapeutics, New York State
- C-Principles of Pharmacology in Drug Discovery 1 | Dr. GPCR Ecosystem
Optimization of Candidate Molecules GPCRs have been and arguably still are the most prolific and fertile therapeutic
- Masterclass | Dr. GPCR Ecosystem
Instructor Watch Now Terry Kenakin Decoding Drug Action Learn the four core drug properties to predict therapeutic
- History Timeline | Dr. GPCR Ecosystem
2022: Virtual Café Series launched - 16 episodes Sep 20, 2022: First contributor article published, Therapeutic
- Flash News: Your Hub for GPCR Insights and Scientific Conference Programs
lesson: Target depletion vs. replenishment dynamics — how offset rates control exposure windows, shape therapeutic The result: inconsistent exposure, patchy activity, and sometimes, outright therapeutic failure. How target depletion and replenishment kinetics define the therapeutic window.
- News | Dr. GPCR Ecosystem
Biased signalling of Class B G protein-coupled receptor-targeted therapeutics Read More April 1, 2025
- Ep 170 with Dr. Alex Serafini
analysis, revealed nuanced roles of RGS4, RGS9, and RGSZ — not just as modulators but as potential therapeutic
- Posters | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
University of Copenhagen, Copenhagen, Denmark. (2) Department of Psychiatry and Molecular Pharmacology and Therapeutics Columbia University Vagelos College of Physicians and Surgeons, New York, USA; Division of Molecular Therapeutics
- Ep 166 with Dr. Ben Clements
Clements' work is primarily focused on translational developments of small molecule therapeutics, and
- Ep 167 with Drs. Tom Sakmar & Ilana Kotliar
This could accelerate discovery of therapeutic targets by combining multiplex data with focused downstream
- Yamina's Corner | Dr. GPCR Ecosystem
Clear Platform Assessment: Gain rapid, independent insight into GPCR platform risks and true therapeutic
- Student Flash Presentations | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
graduate student, he worked in the EuGEF Research Group to identify novel prognostic biomarkers and therapeutic Clearly, a new, less toxic therapeutic is needed.
- Revvity | Dr. GPCR Ecosystem
Whether you’re decoding signaling pathways or designing the next generation of therapeutics, Revvity
- The Practical Assessment of Signaling Bias | Dr. GPCR Ecosystem
. 💊 Therapeutic Potential : Understanding bias enables researchers to design drugs that target specific Kenakin challenges the traditional approach and encourages leveraging bias for better therapeutic outcomes
















